Robuta

https://www.agcbio.com/ Contract Development Manufacturing (CDMO) | Biologics and Cell & Gene Therapies: AGC Biologics contract developmentcdmo biologicsgene therapiesmanufacturingcell https://www.centenary.org.au/news/new-route-into-cells-could-make-gene-therapies-safer/ New route into cells could make gene therapies safer | Centenary Institute Feb 24, 2026 - Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies... new routegene therapiescellscould https://jabonline.in/abstract.php?article_id=1456 Engineering exosome-based gene therapies: Tools, targets, and AI-enabled genomic design gene therapies https://emiratitimes.com/uae-advances-in-regenerative-medicine/ UAE boosts role in regenerative medicine and gene therapies - Emirati Times May 4, 2026 - UAE boosts stem cell and gene therapies, advancing regenerative medicine through innovation, research, and integrated healthcare systems. regenerative medicineuaeboostsrole https://www.progress.org.uk/two-gene-therapies-for-deafness-make-progress/ Two gene therapies for deafness make progress | PET May 5, 2026 - Meta overview of recent clinical trial and regulatory developments in gene therapy for OTOF-related congenital hearing loss. gene therapiesmake progresstwodeafnesspet https://www.middleeasthealthjournal.com/article/854579784-taysha-gene-therapies-announces-fda-breakthrough-therapy-designation-and-provides-positive-regulatory-update-on-tsha-102-in-rett-syndrome Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive... gene therapiesannouncesfda https://www.bioprocessintl.com/therapeutic-modalities/gene-therapies Gene Therapies recent news | BioProcess International Explore the latest news and expert commentary on Gene Therapies, brought to you by the editors of BioProcess International gene therapiesrecent newsbioprocessinternational https://www.raps.org/resource/strategic-regulatory-intelligence-for-cell-and-gene-therapies.html Strategic regulatory intelligence for cell and gene therapies | RAPS This article is the first of two on strategic regulatory intelligence for cell and gene therapies (CGTs). It will examine how gaps between product approvals... cell and gene therapiesregulatory intelligencestrategicraps https://lifesciencetracker.com/entries/taysha-gene-therapies-inc-11-04-2025/ Taysha Gene Therapies Inc. - 11-04-2025 - Incubate Investment Tracker Feb 9, 2026 - These actions, presently directed by executive orders or memoranda from the Office of Management and Budget, may propose policy changes that create additional... gene therapiesincinvestmenttracker https://x-therma.com/news/novel-cryopreservation-for-cell-and-gene-therapies/ Novel Cryopreservation For Cell And Gene Therapies - X-Therma Dec 14, 2023 - The concept of cooling organic materials in order to slow their decay is as old as civilization itself. For the preservation of food, it is as simple as cell and gene therapiesnovelcryopreservationxtherma https://bbmclinicaltrials.com/service/cell-gene-therapies/ Cell & Gene Therapies - British BioMedicine Clinical Trials - "Transforming Health Through... Nov 11, 2024 - BBMCT specializes in managing clinical trials for cell and gene therapies at AIIMS Hospital, specifically focused on Indian patients. Their expert team is... gene therapiesclinical trialstransforming healthcellbritish https://www.raps.org/resource/preparing-for-market-reimbursement-strategies-for.html Preparing for Market: Reimbursement Strategies for Cell and Gene Therapies | RAPS In this interview with Regulatory Focus, Ted Slocomb and Michael Werner, two leaders from the Alliance for Regenerative Medicine (ARM), provide insight into... cell and gene therapiespreparing formarketreimbursementstrategies https://www.motilaloswal.com/us-stocks/tsha Taysha Gene Therapies Inc Share Price Today - TSHA Stock Price Quote gene therapiesshare priceinctodaytsha https://powerusa.org/novel-cell-and-gene-therapies-for-hiv/ Novel Cell and Gene Therapies for HIV - Program for Wellness Restoration Oct 1, 2012 - Although the development of cell-based and gene transfer therapies has been slow, progress in a number of areas is evident. Advances in the fields of... cell and gene therapieshiv programnovelwellnessrestoration https://milkeninstitute.org/content-hub/research-and-reports/reports/cell-and-gene-therapies-looking-ahead-2022 Cell and Gene Therapies: Looking Ahead to 2022 This report summarizes the key takeaways from FasterCures' November 3 roundtable on cell and gene therapies and considers the developments that will take place cell and gene therapieslooking ahead https://www.investmentmonitor.ai/news/astrazeneca-and-cellectis-partner-to-advance-cell-and-gene-therapies/ AstraZeneca and Cellectis partner to advance cell and gene therapies - Investment Monitor Nov 15, 2023 - Cellectis will receive $25m in upfront payment, up to $220m in equity investment, and potential milestone based and royalty payments. gene therapiesastrazenecacellectispartner https://www.bioworld.com/articles/708292-backed-by-54m-biotech-veterans-latus-targets-new-gene-therapies?v=preview Backed by $54M, biotech veterans, Latus targets new gene therapies | BioWorld Philadelphia-based Latus Bio Inc., co-founded by serial biotech entrepreneurs P. Peter Ghoroghchian and Beverly Davidson, launched on May 2 with two lead... backed bygene therapiesbiotechveterans https://biopharmacurated.com/editorial/the-cmc-challenge-of-scaling-cell-and-gene-therapies/ The CMC Challenge of Scaling Cell and Gene Therapies | Biopharma Curated Mar 18, 2026 - Advanced Therapy Medicinal Products cannot be scaled the same way biologics were. The core constraint is not steel and glass. It is biology, variability, and a... cell and gene therapiescmcchallengescaling https://thesocialdelight.com/story6933311/unveiling-cellular-and-gene-therapies-a-comprehensive-faq-guide Unveiling Cellular and Gene Therapies: A Comprehensive FAQ Guide gene therapiescomprehensive faqunveilingcellularguide https://www.macrotrends.net/stocks/charts/TSHA/taysha-gene-therapies/revenue Taysha Gene Therapies Revenue 2020-2025 | TSHA | MacroTrends Taysha Gene Therapies revenue from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales... gene therapiesrevenuetshamacrotrends https://www.joinexpeditions.com/collections/1112-dna-and-gene-therapies DNA and gene therapies - EXPeditions We have two metres of DNA inside each of our cells. Genes are collections: an ensemble of genomic sequences made of DNA which have a coherent function and lie... gene therapiesdnaexpeditions https://accentbio.com/new-approach-for-efficient-engineering-of-cell-and-gene-therapies-52/ New approach for efficient engineering of cell and gene therapies - Accentbio Apr 30, 2023 - A new approach to the genetic engineering of cells promises significant improvements in speed, efficiency, and reduction in cellular toxicity compared to curren cell and gene therapiesnew approachefficientengineering https://bookmarksbay.com/story21384129/unveiling-cellular-and-gene-therapies-a-comprehensive-faq-guide Unveiling Cellular and Gene Therapies: A Comprehensive FAQ Guide gene therapiescomprehensive faqunveilingcellularguide https://www.fortrea.com/therapeutics/cell-and-gene-therapies Cell and Gene Therapies | Fortrea Fortrea offers advanced cell and gene therapies, focusing on genetic medicine and gene editing. Discover our innovative approaches to genetic treatment... cell and gene therapiesfortrea https://iowahealthcarereporter.com/article/854579784-taysha-gene-therapies-announces-fda-breakthrough-therapy-designation-and-provides-positive-regulatory-update-on-tsha-102-in-rett-syndrome Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive... gene therapiesannouncesfda https://www.americangene.com/ American Gene Technologies: Developing Gene And Cell Therapies Mar 8, 2026 - American Gene Technologies™ (AGT) is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. american gene technologiesdevelopingcelltherapies https://www.niuehealthreport.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://www.fiercebiotech.com/biotech/taysha-gene-therapies-hits-ground-running-30m-15-programs Taysha Gene Therapies hits the ground running with $30M, 15 programs | Fierce Biotech Apr 29, 2020 - The team that developed Zolgensma is back for round two. https://trinidadtobagobusinessnews.com/article/836298026-taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Trinidad &... https://www.troutman.com/insights/personalized-therapies-customized-deals-practical-strategies-for-cell-gene-therapy-licensing/ Personalized Therapies, Customized Deals: Practical Strategies for Cell & Gene Therapy Licensing -... Apr 7, 2026 - Join Troutman Pepper Locke attorneys EA Weeks, Judy O’Grady, and Heather Ettinger for a webinar exploring how the explosive growth of cell and gene therapy practical strategiesgene therapypersonalizedtherapiescustomized https://palestinehealthreport.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://www.medtherapybiotech.com/team/graham-morrell-biography.html Graham Morrell Biography - MedTherapy | Cell, gene and immunological therapies Aug 20, 2023 - At MedTherapy, we work to create a healthier world through advanced cell-based therapies with unparalleled quality grahammorrellbiographycellgene https://www.fiercebiotech.com/biotech/neurogene-inks-neoleukin-reverse-merger-raises-95m-fund-gene-therapies-clinical-data-drops Neurogene inks Neoleukin reverse merger to fund gene therapies Jul 18, 2023 - Neurogene has agreed to merge with the Nasdaq-listed Neoleukin Therapeutics and persuaded investors to pump $95 million into the combined company. inksreversemergerfundgene https://middleeasthealthjournal.com/article/864182056-taysha-gene-therapies-reports-third-quarter-2025-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports Third Quarter 2025 Financial Results and Provides Corporate Update |... https://indianatechwatch.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://healthchanneltogo.com/article/836298026-taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Health... https://www.europeanglobe.com/article/845693526-kfshrc-strengthens-global-leadership-with-breakthrough-in-cell-and-gene-therapies KFSHRC Strengthens Global Leadership with Breakthrough in Cell and Gene Therapies | European Globe European Globe is an online news publication focusing on the Europe: Following the news from Europe cell and gene therapies https://lowvision.preventblindness.org/gene-profiling-technique-accelerates-stem-sell-therapies-for-retinal-diseases/ Gene Profiling Technique Accelerates Stem Cell Therapies for Retinal Diseases - Living Well With... Sep 23, 2014 - (Source: National Eye Institute, National Institutes of Health) Researchers at the National Institutes of Health have developed a technique that will stem cell therapies https://wiseek.ai/ticker/prme/news/prime-medicine-extends-cash-runway-into-2027-advances-two-key-gene-therapies-to-clinic-0df2de71d1469ec04be75a905eb39a48bcda6e3b85560fce69d940a69a51d6f8/ Prime Medicine Extends Cash Runway into 2027, Advances Two Key Gene Therapies to Clinic May 7, 2026 - Prime Medicine reported first-quarter 2026 financial results, announcing a cash position of $149.2 million as of March 31, 2026. https://www.healthheraldgrenada.com/article/845700187-kfshrc-reinforces-global-leadership-as-early-adopter-of-advanced-cell-and-gene-therapies KFSHRC Reinforces Global Leadership as Early Adopter of Advanced cell and Gene Therapies | Health... cell and gene therapies https://www.scienceandtechnologywatch.com/article/855043259-taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Science &... https://survivornet.ca/events/webinar-realising-the-potential-of-cell-and-gene-therapies/ Webinar: Realising the potential of cell and gene therapies - Canadian Cancer Survivor Network Cell and gene therapy (CGT) can be a revolutionary tool to prevent, treat or even cure life-threatening diseases. Some 45 cell or gene therapies are available,... cell and gene therapies https://technologyreviewmississippi.com/article/855043259-taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Technology... https://idahohealthcarehub.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://healthwireburundi.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://scitechworlddelaware.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://biopharmaapac.com/news/28/5941/phc-corporation-partners-with-ccrm-to-advance-t-cell-expansion-for-cell-and-gene-therapies.html PHC Corporation Partners with CCRM to Advance T-Cell Expansion for Cell and Gene Therapies PHC Corporation Partners with CCRM to Advance T-Cell Expansion for Cell and Gene Therapies https://exegenesisbio.com/ Exegenesis Bio – gene and cell therapies biogenecelltherapies https://www.gene-therapies.org/ Institute for Gene Therapies The Institute for Gene Therapies advocates for a modernized regulatory and reimbursement framework that encourages the development of transformative gene... institutegenetherapies https://www.eastonspectator.com/2026/05/06/the-vaccine-cartel-and-us-army-are-developing-13-hantavirus-vaccines-and-gene-therapies/ The Vaccine Cartel and US Army Are Developing 13 Hantavirus Vaccines and Gene Therapies - Easton... Mary Talley Bowden, MD – Hantavirus is a RNA virus, and ivermectin should work against it. Ivermectin blocks RNA viruses from entering the nucleus, inhibits... https://www.northdakotahealthcarenewswire.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://www.surinamebusinessdaily.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://www.outsourcedpharma.com/doc/trends-in-next-generation-delivery-technologies-to-advance-gene-modified-cell-therapies-0001 Trends In Next-Generation Delivery Technologies To Advance Gene-Modified Cell Therapies Learn how lipid nanoparticles are enabling a new generation of engineered cell therapies with a push toward more complex cell engineering and gene editing for... next generation https://tennesseejournaloftechnology.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://www.healthcareweeklyjamaica.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://unlimited.bio/ Unlimited Bio: Advanced Rejuvenation with Gene Therapies bio advancedunlimitedrejuvenationgenetherapies https://www.northcarolinawellnessnews.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://www.alliedacademies.org/articles/rna-therapeutics-development-of-mrna-vaccines-and-gene-silencing-therapies-29810.html RNA therapeutics: Development of mRNA vaccines and gene silencing therapies. rna therapeuticsmrna vaccinesgene silencingdevelopmenttherapies https://www.truth11.com/untitled-1019/ Five States Have Introduced Bills Restricting The Use Of mRNA Or Gene Therapies In Livestock Or... Apr 23, 2023 - ZeroHedge News | Tyler Durden Controversial mRNA Technology Now Targeting Livestock Allan Stein | The Epoch Times At least five states have introduced bills... https://cell-press-symposia.com/cell-therapies-2020/conference-speakers.html Conference Speakers: Cell Symposia: Gene- and Cell-Based Therapies: CRISPR, Stem Cells, and Beyond Cell Symposium: Cell Symposia: Gene- and Cell-Based Therapies: CRISPR, Stem Cells, and Beyond conference speakers https://www.clinicalleader.com/doc/crafting-an-effective-commercialization-strategy-for-cell-and-gene-therapies-0001 Crafting An Effective Commercialization Strategy For Cell And Gene Therapies Patient access and manufacturing efficiency persist as barriers to widespread adoption of CGTs. An effective commercialization strategy is crucial to expand... cell and genecommercialization strategycraftingeffectivetherapies https://www.susupport.com/blogs/news/single-use-support-investing-end-to-end-solutions-cell-gene-therapies Single Use Support investing in end-to-end solutions for cell & gene therapies single use https://cos.northeastern.edu/valery-pamela-trujillo-benitez-25-cell-and-gene-therapies/ Valery Pamela Trujillo Benitez '25, MS Cell and Gene Therapies - Northeastern University College of... May 14, 2025 - Valery Pamela Trujillo Benitez shares her experiences as a master's student studying cell and gene therapies. cell and gene therapies https://www.healthworldmauritania.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://www.techbulletinbarbados.com/article/836298026-taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Tech... https://healthmonthlymartinique.com/article/855043259-taysha-gene-therapies-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Health... https://www.synconaltd.com/news-insights/news/freeline-presents-on-its-fabry-and-gaucher-disease-aav-based-gene-therapies-at-the-18th-annual-worldsymposiumtm/ Freeline Presents on Its Fabry and Gaucher Disease AAV-Based Gene Therapies at the 18th Annual... https://stemtimesarkansas.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://chemistry.berkeley.edu/news/meet-our-faculty-david-schaffer-pioneer-bioengineering-and-gene-therapies Meet our faculty: David Schaffer, pioneer in bioengineering and gene therapies | College of... meet our faculty https://www.genengnews.com/multimedia/podcasts/gencast/smart-vector-design-for-improved-cell-and-gene-therapies/ Smart Vector Design for Improved Cell and Gene Therapies Jun 17, 2025 - In this GENCast, experts discuss current immunogenicity hurdles, evolving DMPK strategies, and a new generation of bioanalytical tools that are contributing to... cell and genesmart vectordesignimprovedtherapies https://www.myanmartechnologybulletin.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://www.rdworldonline.com/adverum-editas-announce-plan-to-develop-gene-editing-therapies-for-eye-diseases/ Adverum, Editas Announce Plan to Develop Gene Editing Therapies for Eye Diseases - Research &... https://researchinformation.umcutrecht.nl/en/activities/prime-time-for-gene-correction-therapies-targeting-the-liver/ Prime time for gene-correction therapies targeting the liver - University Medical Center Utrecht https://montserrattechupdate.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |... https://www.modernretina.com/view/pulsesight-therapeutics-launches-to-advance-non-viral-gene-therapies-for-severe-retinal-diseases PulseSight Therapeutics launches to advance non-viral gene therapies for severe retinal diseases |... May 18, 2026 - According to the company, its proprietary non-viral gene therapy platform with minimally invasive delivery technology is providing long lasting gene expression... https://www.virginiastemnews.com/article/910796168-taysha-gene-therapies-reports-first-quarter-2026-financial-results-and-provides-corporate-update Taysha Gene Therapies Reports First Quarter 2026 Financial Results and Provides Corporate Update |...